Tag: VUITY
Press Release: Allergan, an AbbVie Company, Announces Positive Topline Phase 3...
April 5, 2022
VUITY is the first and only eye drop to treat presbyopia, or age-related blurry near vision, in adults and is FDA-approved for...
Press Release: U.S. Food and Drug Administration Approves VUITY™ (pilocarpine HCI...
Allergan, an AbbVie (NYSE: ABBV) company, today announced the U.S. Food and Drug Administration (FDA) approval of VUITY™ (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. VUITY is the first and only FDA-approved eye drop to treat this common and progressive eye condition that affects 128 million Americans, nearly half of the U.S. adult population.